|
Asamblea Biosciences, Inc. (ASMB) Valoración de DCF
US | Healthcare | Biotechnology | NASDAQ
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
Assembly Biosciences, Inc. (ASMB) Bundle
¡Streamline Assembly Biosciences, Inc. (ASMB) Valoración con esta calculadora DCF versátil! Con Real Assembly Biosciences, Inc. (ASMB) Financials y entradas de pronóstico ajustable, puede explorar varios escenarios y determinar el valor razonable de Biosciences, Inc. (ASMB) de Asamblea (ASMB) en solo minutos.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 16.0 | 79.1 | 6.3 | .0 | 7.2 | 5.5 | 4.2 | 3.3 | 2.5 | 1.9 |
| Revenue Growth, % | 0 | 395.55 | -92.09 | -100 | 0 | -23.02 | -23.02 | -23.02 | -23.02 | -23.02 |
| EBITDA | -102.7 | -64.8 | -91.9 | -92.6 | -64.2 | -3.1 | -2.4 | -1.8 | -1.4 | -1.1 |
| EBITDA, % | -643.44 | -81.89 | -1469.97 | 100 | -896.22 | -56.38 | -56.38 | -56.38 | -56.38 | -56.38 |
| Depreciation | .5 | .7 | .5 | .5 | .5 | 1.3 | 1.0 | .8 | .6 | .5 |
| Depreciation, % | 3.09 | 0.87352 | 7.45 | 100 | 6.28 | 23.54 | 23.54 | 23.54 | 23.54 | 23.54 |
| EBIT | -103.2 | -65.5 | -92.4 | -93.1 | -64.6 | -3.1 | -2.4 | -1.8 | -1.4 | -1.1 |
| EBIT, % | -646.54 | -82.76 | -1477.42 | 100 | -902.5 | -56.55 | -56.55 | -56.55 | -56.55 | -56.55 |
| Total Cash | 274.0 | 216.4 | 146.6 | 91.6 | 130.2 | 5.5 | 4.2 | 3.3 | 2.5 | 1.9 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 3.4 | 1.2 | .3 | .9 | .0 | 1.4 | 1.1 | .8 | .6 | .5 |
| Account Receivables, % | 21.14 | 1.55 | 5.37 | 100 | 0.60031 | 25.73 | 25.73 | 25.73 | 25.73 | 25.73 |
| Inventories | .0 | .0 | .0 | .0 | -3.2 | .6 | .5 | .4 | .3 | .2 |
| Inventories, % | 0 | 0 | 0.000015989767 | 100 | -44.63 | 11.07 | 11.07 | 11.07 | 11.07 | 11.07 |
| Accounts Payable | 1.7 | 4.6 | 2.7 | 2.5 | .5 | 1.8 | 1.4 | 1.1 | .8 | .6 |
| Accounts Payable, % | 10.84 | 5.81 | 42.52 | 100 | 6.44 | 33.12 | 33.12 | 33.12 | 33.12 | 33.12 |
| Capital Expenditure | -1.6 | -2.2 | -3.1 | -.1 | -.3 | -.7 | -.6 | -.4 | -.3 | -.3 |
| Capital Expenditure, % | -9.74 | -2.81 | -49.5 | 100 | -3.56 | -13.12 | -13.12 | -13.12 | -13.12 | -13.12 |
| Tax Rate, % | -0.05392597 | -0.05392597 | -0.05392597 | -0.05392597 | -0.05392597 | -0.05392597 | -0.05392597 | -0.05392597 | -0.05392597 | -0.05392597 |
| EBITAT | -102.4 | -62.7 | -90.6 | -92.1 | -64.7 | -3.1 | -2.4 | -1.8 | -1.4 | -1.1 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -105.1 | -59.2 | -94.3 | -92.4 | -62.4 | -6.3 | -1.9 | -1.4 | -1.1 | -.9 |
| WACC, % | 7.13 | 7.13 | 7.13 | 7.13 | 7.13 | 7.13 | 7.13 | 7.13 | 7.13 | 7.13 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -10.1 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -1 | |||||||||
| Terminal Value | -17 | |||||||||
| Present Terminal Value | -12 | |||||||||
| Enterprise Value | -22 | |||||||||
| Net Debt | -17 | |||||||||
| Equity Value | -5 | |||||||||
| Diluted Shares Outstanding, MM | 5 | |||||||||
| Equity Value Per Share | -1.02 |
What You Will Get
- Pre-Filled Financial Model: Assembly Biosciences' actual data enables precise DCF valuation.
- Full Forecast Control: Adjust revenue growth, margins, WACC, and other key drivers specific to ASMB.
- Instant Calculations: Automatic updates ensure you see results as you make changes in real-time.
- Investor-Ready Template: A polished Excel file designed for professional-grade valuation of Assembly Biosciences.
- Customizable and Reusable: Tailored for flexibility, allowing repeated use for detailed forecasts on ASMB.
Key Features
- Comprehensive Data: Assembly Biosciences' historical financial statements and detailed projections.
- Customizable Parameters: Adjust inputs such as WACC, tax rates, revenue growth, and EBITDA margins.
- Real-Time Insights: View Assembly Biosciences' intrinsic value update instantly.
- Intuitive Visualizations: Dashboard graphs illustrate valuation outcomes and essential metrics.
- Designed for Precision: A reliable tool for analysts, investors, and finance professionals.
How It Works
- Download the Template: Gain immediate access to the Excel-based ASMB DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and more.
- Instant Calculations: The model automatically recalculates Assembly Biosciences’ intrinsic value.
- Test Scenarios: Experiment with various assumptions to assess potential valuation shifts.
- Analyze and Decide: Utilize the findings to inform your investment or financial analysis.
Why Choose This Calculator for Assembly Biosciences, Inc. (ASMB)?
- Accuracy: Utilizes real Assembly Biosciences financial data for precise calculations.
- Flexibility: Allows users to easily adjust and test various input parameters.
- Time-Saving: Eliminate the need to create a DCF model from the ground up.
- Professional-Grade: Crafted with the expertise and usability expected at the CFO level.
- User-Friendly: Intuitive design makes it accessible for users without extensive financial modeling skills.
Who Should Use This Product?
- Professional Investors: Develop comprehensive and accurate valuation models for investment analysis in Assembly Biosciences, Inc. (ASMB).
- Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decisions within their organizations.
- Consultants and Advisors: Deliver precise valuation insights for clients interested in Assembly Biosciences, Inc. (ASMB).
- Students and Educators: Utilize real-world data to enhance learning and practice in financial modeling.
- Biotech Enthusiasts: Gain insights into how biotechnology firms like Assembly Biosciences, Inc. (ASMB) are valued in the market.
What the Template Contains
- Historical Data: Includes Assembly Biosciences, Inc.'s (ASMB) past financials and baseline forecasts.
- DCF and Levered DCF Models: Detailed templates to calculate Assembly Biosciences, Inc.'s (ASMB) intrinsic value.
- WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
- Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
- Quarterly and Annual Statements: A complete breakdown of Assembly Biosciences, Inc.'s (ASMB) financials.
- Interactive Dashboard: Visualize valuation results and projections dynamically.